InvestorGain adds IPO, Buybacks & Authorizations, Secondary Offerings, New Issues & Calendars, and Education coverage that ORTEX skips.
VOL. XCIV, NO. 247
★ FINANCIAL TOOLS & SERVICES DIRECTORY ★
PRICE: 5 CENTS
Sunday, October 19, 2025
Head-to-head
InvestorGain vs ORTEX comparison
Compare pricing, supported platforms, categories, and standout capabilities to decide which tool fits your workflow.
Quick takeaways
ORTEX includes Short Interest, Insider Data, Quant, Data Visualizations, Index Rebalancing, Money Flow, Options & Derivatives, Options, Analyst Recommendations, Analyst Price Targets, News, Data APIs, US Government Trades, and Screeners categories that InvestorGain omits.
InvestorGain highlights: Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP)., Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues., and IPO anchor investor allocation reports by year (mainboard & SME)..
ORTEX is known for: Short interest and lending analytics including utilization, cost to borrow, shares on loan, and percentage of free float on loan, with intraday and real-time estimates from a large pool of lenders and brokers., Official U.S. exchange-reported short interest (bi-monthly) and European flagged shorts, alongside lending-based estimates., and Options coverage with unusual activity and flow detection; OPRA-sourced data gated by user agreement to OPRA terms..
InvestorGain
investorgain.com
India‑focused IPO & primary‑markets portal with live IPO subscription tracking, Grey Market Premium (GMP) dashboards, anchor investor allocations, and new‑issue calendars (NCDs, SGBs, rights). Provides broker reviews/comparisons and free brokerage calculators. GMP is expressly noted as based on market perception/public sources; the site states it does not work with GMP operators and content is for education/news. The business is ad/affiliate‑supported.
Categories
Platforms
Pricing
Quick highlights
- Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP).
- Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues.
- IPO anchor investor allocation reports by year (mainboard & SME).
- IPO performance history and GMP‑vs‑actual listing performance trackers.
- Rights issues dashboard (record date, entitlement, pricing, timelines).
Community votes (overall)
ORTEX
public.ortex.com
Analytics platform focused on short interest and securities lending, with additional coverage of options flow, insider trades, analyst views, and index rebalances. Offers a free tier with limited features, plus paid plans (Basic $39/mo, Advanced $129/mo). Options data is sourced from OPRA and requires agreeing to OPRA terms. API access is available with key-based authentication, and an Excel Add-in (beta) supports short interest data.
Categories
Platforms
Pricing
Quick highlights
- Short interest and lending analytics including utilization, cost to borrow, shares on loan, and percentage of free float on loan, with intraday and real-time estimates from a large pool of lenders and brokers.
- Official U.S. exchange-reported short interest (bi-monthly) and European flagged shorts, alongside lending-based estimates.
- Options coverage with unusual activity and flow detection; OPRA-sourced data gated by user agreement to OPRA terms.
- Alpha trading signals across themes like Short Squeeze, EPS, RSI, MACD, and Company Events, each with back-tested stats and intraday updates.
- Configurable stock screener including short-interest columns; results can be exported.
Community votes (overall)
Shared focus areas
2 overlapsMutual strengths include Calendar, and Blogs.
Where they differ
InvestorGain
Distinct strengths include:
- Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP).
- Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues.
- IPO anchor investor allocation reports by year (mainboard & SME).
- IPO performance history and GMP‑vs‑actual listing performance trackers.
ORTEX
Distinct strengths include:
- Short interest and lending analytics including utilization, cost to borrow, shares on loan, and percentage of free float on loan, with intraday and real-time estimates from a large pool of lenders and brokers.
- Official U.S. exchange-reported short interest (bi-monthly) and European flagged shorts, alongside lending-based estimates.
- Options coverage with unusual activity and flow detection; OPRA-sourced data gated by user agreement to OPRA terms.
- Alpha trading signals across themes like Short Squeeze, EPS, RSI, MACD, and Company Events, each with back-tested stats and intraday updates.
Feature-by-feature breakdown
Attribute | InvestorGain | ORTEX |
---|---|---|
Categories Which research workflows each platform targets | Shared: Calendar, Blogs Unique: IPO, Buybacks & Authorizations, Secondary Offerings, New Issues & Calendars, Education | Shared: Calendar, Blogs Unique: Short Interest, Insider Data, Quant, Data Visualizations, Index Rebalancing, Money Flow, Options & Derivatives, Options, Analyst Recommendations, Analyst Price Targets, News, Data APIs, US Government Trades, Screeners |
Asset types Supported asset classes and universes | Stocks, Bonds | Stocks, ETFs, Options |
Experience levels Who each product is built for | Beginner, Intermediate, Advanced | Beginner, Intermediate, Advanced |
Platforms Where you can access the product | Web, Mobile | Web, Mobile, API |
Pricing High-level pricing models | Free | Free, Subscription |
Key features Core capabilities called out by each vendor | Unique
| Unique
|
Tested Verified by hands-on testing inside Find My Moat | Not yet | Yes |
Editor pick Featured inside curated shortlists | Standard listing | Standard listing |
Frequently Asked Questions
Which workflows do InvestorGain and ORTEX both support?
Both platforms cover Calendar, and Blogs workflows, so you can research those use cases in either tool before digging into the feature differences below.
Do InvestorGain and ORTEX require subscriptions?
Both InvestorGain and ORTEX keep freemium access with optional paid upgrades, so you can trial each platform before committing.
How can you access InvestorGain and ORTEX?
Both InvestorGain and ORTEX support web and mobile access, making it easy to keep tabs on research away from the desk.
What unique strengths set the two platforms apart?
InvestorGain differentiates itself with Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP)., Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues., and IPO anchor investor allocation reports by year (mainboard & SME)., whereas ORTEX stands out for Short interest and lending analytics including utilization, cost to borrow, shares on loan, and percentage of free float on loan, with intraday and real-time estimates from a large pool of lenders and brokers., Official U.S. exchange-reported short interest (bi-monthly) and European flagged shorts, alongside lending-based estimates., and Options coverage with unusual activity and flow detection; OPRA-sourced data gated by user agreement to OPRA terms..
Keep exploring
Stay on top of related tools
Browse the categories and profiles that overlap most with this comparison to round out your shortlist.
Related categories
Follow the same themes these tools compete in.
Recommended tools
These profiles share overlapping coverage with both sides of this matchup.
- MarketWatchHands-on review
Overlap: News, Calendar, and Screeners.
NewsCalendarScreeners - Nasdaq.comHands-on review
Overlap: Screeners, News, and Calendar.
ScreenersNewsCalendar - TrendlyneHands-on review
Overlap: Screeners, Analyst Price Targets, and Analyst Recommendations.
ScreenersAnalyst Price TargetsAnalyst Recommendations - Stocknear
Overlap: Screeners, Options & Derivatives, and Data Visualizations.
ScreenersOptions & DerivativesData Visualizations - StockopediaEditor's pickHands-on review
Overlap: Screeners, Data Visualizations, and Analyst Recommendations.
ScreenersData VisualizationsAnalyst Recommendations - Unusual WhalesEditor's pickHands-on review
Overlap: Screeners, Options & Derivatives, and News.
ScreenersOptions & DerivativesNews
Curation & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.